Sitravatinib (MGCD516) is an experimental drug for the treatment of cancer. It is a small molecule inhibitor of multiple tyrosine kinases. Reference standards of Sitravatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Sitravatinib
Catalogue No.:PA 19 1710000
CAS :
Molecular Formula : C33H29F2N5O4S
Molecular Weight : 629.68
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
